|
Volumn 196, Issue 4, 2008, Pages 519-522
|
Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomy
|
Author keywords
Breast cancer; Implant expander; Neoadjuvant chemotherapy
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOCETAXEL;
EPIRUBICIN;
ARTICLE;
BREAST CANCER;
BREAST RECONSTRUCTION;
CANCER ADJUVANT THERAPY;
CANCER PATIENT;
CANCER STAGING;
DEVICE REMOVAL;
FEMALE;
HUMAN;
IMPLANT;
INFECTION;
MAJOR CLINICAL STUDY;
MASTECTOMY;
MULTIPLE CYCLE TREATMENT;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
ADULT;
BREAST IMPLANTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
MAMMAPLASTY;
MASTECTOMY;
PROSPECTIVE STUDIES;
PROSTHESIS FAILURE;
RISK FACTORS;
TISSUE EXPANSION DEVICES;
|
EID: 52049120591
PISSN: 00029610
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjsurg.2008.06.016 Document Type: Article |
Times cited : (52)
|
References (9)
|